Age-related neuropsychiatric diseases are pathologies of the central nervous systems characterized by loss of brain functions and problems in cognitive impairment and emotional instability associated with progressive degeneration in aging populations. Neuropsychiatric diseases such as anxiety, depression, PTSD, delirium, and other mood disorders are widely known. Age-related neuropsychiatric diseases are a significant burden on society and individuals.
In recent years, many studies on mechanisms underlying these age-related neuropsychiatric pathologies and abundant attempts to develop new treatment strategies have been conducted. Especially with the progress of neural circuitry technology, the brain functional regulation mechanism in age-related neuropsychiatric diseases has been increasingly studied over the last few years. And to fight the diseases, researchers have developed a range of novel therapeutic strategies including some new pharmacological approaches, e.g., transcranial magnetic stimulation. But unfortunately, the pathogenesis of these diseases is not yet fully understood, which restricts the development of new drugs and novel therapeutic strategies. Therefore, some complementary and alternative therapeutic methods are still urgent in the clinic.
This Research Topic aims to report recent discoveries about the novel pathomechanisms and therapeutic innovations on age-related neuropsychiatric diseases. Original Research, Review, Opinion, and Perspective articles will be considered for publication. We would specifically encourage studies in, but not limited to, the following topics:
•New electrophysiological or neural circuit mechanisms about functional pathogenesis of neuropsychiatric diseases in the elderly and the therapeutic strategies.
•Molecular or genetic mechanisms of neuropsychiatric diseases in the elderly and the therapeutic strategies, including using existing models, paradigms, and/or therapies.
•New potential therapeutic strategies against neuropsychiatric diseases in the elderly, including traditional Chinese medicine and non-pharmaceutical therapy.
Age-related neuropsychiatric diseases are pathologies of the central nervous systems characterized by loss of brain functions and problems in cognitive impairment and emotional instability associated with progressive degeneration in aging populations. Neuropsychiatric diseases such as anxiety, depression, PTSD, delirium, and other mood disorders are widely known. Age-related neuropsychiatric diseases are a significant burden on society and individuals.
In recent years, many studies on mechanisms underlying these age-related neuropsychiatric pathologies and abundant attempts to develop new treatment strategies have been conducted. Especially with the progress of neural circuitry technology, the brain functional regulation mechanism in age-related neuropsychiatric diseases has been increasingly studied over the last few years. And to fight the diseases, researchers have developed a range of novel therapeutic strategies including some new pharmacological approaches, e.g., transcranial magnetic stimulation. But unfortunately, the pathogenesis of these diseases is not yet fully understood, which restricts the development of new drugs and novel therapeutic strategies. Therefore, some complementary and alternative therapeutic methods are still urgent in the clinic.
This Research Topic aims to report recent discoveries about the novel pathomechanisms and therapeutic innovations on age-related neuropsychiatric diseases. Original Research, Review, Opinion, and Perspective articles will be considered for publication. We would specifically encourage studies in, but not limited to, the following topics:
•New electrophysiological or neural circuit mechanisms about functional pathogenesis of neuropsychiatric diseases in the elderly and the therapeutic strategies.
•Molecular or genetic mechanisms of neuropsychiatric diseases in the elderly and the therapeutic strategies, including using existing models, paradigms, and/or therapies.
•New potential therapeutic strategies against neuropsychiatric diseases in the elderly, including traditional Chinese medicine and non-pharmaceutical therapy.